# Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

> **NCT00129090** · PHASE3 · COMPLETED · sponsor: **German High-Grade Non-Hodgkin's Lymphoma Study Group** · enrollment: 450 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma (NHL)

## Interventions

- **DRUG:** R-CHOEP 14 with 12x Rituximab

## Key facts

- **NCT ID:** NCT00129090
- **Lead sponsor:** German High-Grade Non-Hodgkin's Lymphoma Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2014-10
- **Final completion:** 2017-10
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129090, "Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00129090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*